LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Clinical Impact of Supplementation with Pasteurized Donor Human Milk by High-Temperature Short-Time Method versus Holder Method in Extremely Low Birth Weight Infants: A Multicentre Randomized Controlled Trial.

García-Lara, Nadia Raquel / Escuder-Vieco, Diana / Cabrera-Lafuente, Marta / Keller, Kristin / De Diego-Poncela, Cristina / Jiménez-González, Concepción / Núñez-Ramos, Raquel / Flores-Antón, Beatriz / Escribano-Palomino, Esperanza / Alonso-Díaz, Clara / Vázquez-Román, Sara / Ureta-Velasco, Noelia / Cruz-Bértolo, Javier De La / Pallás-Alonso, Carmen Rosa

Nutrients

2024  Volume 16, Issue 7

Abstract: Nosocomial infections are a frequent and serious problem in extremely low birth weight (ELBW) infants. Donor human milk (DHM) is the best alternative for feeding these babies when mother's own milk (MOM) is not available. Recently, a patented prototype ... ...

Abstract Nosocomial infections are a frequent and serious problem in extremely low birth weight (ELBW) infants. Donor human milk (DHM) is the best alternative for feeding these babies when mother's own milk (MOM) is not available. Recently, a patented prototype of a High-Temperature Short-Time (HTST) pasteurizer adapted to a human milk bank setting showed a lesser impact on immunologic components. We designed a multicentre randomized controlled trial that investigates whether, in ELBW infants with an insufficient MOM supply, the administration of HTST pasteurized DHM reduces the incidence of confirmed catheter-associated sepsis compared to DHM pasteurized with the Holder method. From birth until 34 weeks postmenstrual age, patients included in the study received DHM, as a supplement, pasteurized by the Holder or HTST method. A total of 213 patients were randomized; 79 (HTST group) and 81 (Holder group) were included in the analysis. We found no difference in the frequency of nosocomial sepsis between the patients of the two methods-41.8% (33/79) of HTST group patients versus 45.7% (37/81) of Holder group patients, relative risk 0.91 (0.64-1.3),
MeSH term(s) Infant ; Infant, Newborn ; Humans ; Infant, Extremely Low Birth Weight ; Milk, Human ; Temperature ; Dietary Supplements ; Sepsis/epidemiology ; Sepsis/prevention & control
Language English
Publishing date 2024-04-08
Publishing country Switzerland
Document type Randomized Controlled Trial ; Multicenter Study ; Journal Article
ZDB-ID 2518386-2
ISSN 2072-6643 ; 2072-6643
ISSN (online) 2072-6643
ISSN 2072-6643
DOI 10.3390/nu16071090
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top